Cellectis S.A.
CLLS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $52 | $60 | $128 | $143 |
| Short-Term Investments | $0 | $136 | $114 | $117 |
| Receivables | $8 | $29 | $26 | $23 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $161 | $2 | $2 | $0 |
| Total Curr. Assets | $221 | $231 | $272 | $287 |
| Property Plant & Equip (Net) | $67 | $70 | $73 | $76 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $0 | $1 |
| Long-Term Investments | $0 | $2 | $2 | $8 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $54 | $50 | $17 | $12 |
| Total NC Assets | $122 | $123 | $92 | $96 |
| Other Assets | $0 | -$0 | $0 | -$0 |
| Total Assets | $343 | $354 | $364 | $384 |
| Liabilities | – | – | – | – |
| Payables | $16 | $18 | $17 | $19 |
| Short-Term Debt | $0 | $5 | $5 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $113 | $113 | $112 |
| Other Curr. Liab. | $124 | $16 | $14 | $13 |
| Total Curr. Liab. | $149 | $167 | $163 | $166 |
| LT Debt | $0 | $50 | $46 | $44 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $65 | $8 | $6 | $17 |
| Total NC Liab. | $94 | $89 | $85 | $95 |
| Other Liabilities | $0 | $0 | $0 | -$9 |
| Cap. Leases | $38 | $40 | $41 | $43 |
| Total Liabilities | $243 | $257 | $248 | $253 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $6 | $6 | $6 |
| Retained Earnings | -$308 | -$308 | -$348 | -$330 |
| AOCI | -$33 | -$34 | -$37 | -$40 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $100 | $97 | $116 | $131 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $343 | $354 | $364 | $384 |
| Net Debt | -$52 | -$5 | -$77 | -$94 |